Cargando…
Knowledge Gaps for Prophylactic Use of Antithrombotic Agents in Patients with COVID-19: Insights into New SARS-CoV-2 Variants, Vaccination Status, and Emerging Oral Antivirals
Data suggest that coronavirus disease 2019 (COVID-19) results in a prothrombotic state leading to arterial and venous thromboses. Vaccination, novel antiviral drugs, and emerging variants have changed the course of the disease in many ways; however, their effects on the incidence of thrombotic event...
Autores principales: | Talasaz, Azita H., Sadeghipour, Parham, Mehdizadeh, Kasra, Khoshnam Rad, Niloofar, Bikdeli, Behnood, Lip, Gregory Y. H., Harenberg, Job |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2022
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9904967/ https://www.ncbi.nlm.nih.gov/pubmed/36206775 http://dx.doi.org/10.1055/a-1956-9641 |
Ejemplares similares
-
Recent Randomized Trials of Antithrombotic Therapy for Patients With COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021) -
Investigating Lipid-Modulating Agents for Prevention or Treatment of COVID-19: JACC State-of-the-Art Review
por: Talasaz, Azita H., et al.
Publicado: (2021) -
Cross-cultural validity of the Pulmonary Embolism Quality of Life questionnaire in the quality of life survey after pulmonary embolism: A Persian-speaking cohort
por: Mehdizadeh, Kasra, et al.
Publicado: (2023) -
Cardiovascular Complications of COVID-19: Pharmacotherapy Perspective
por: Talasaz, Azita Hajhossein, et al.
Publicado: (2020) -
Anticoagulation in COVID-19: Randomized trials should set the balance between excitement and evidence
por: Bikdeli, Behnood
Publicado: (2020)